Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 09:57 am Purchase |
2020-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
CVI Investments, Inc. | 18,732 4.900% |
86 (+0.46%) |
Filing History |
| 2021-02-12 4:58 pm Purchase |
2020-12-18 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
ACORN BIOVENTURES, L.P. | 156,299 9.990% |
156,299 (New Position) |
Filing History |
| 2021-02-11 09:41 am Unchanged |
2020-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Renaissance Technologies LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-02-09 2:28 pm Purchase |
2020-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Hudson Bay Capital Management LP | 27,500 7.160% |
27,500 (New Position) |
Filing History |
| 2021-01-08 9:59 pm Purchase |
2020-12-23 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Ikarian Capital LLC | 26,667 8.200% |
26,667 (New Position) |
Filing History |
| 2020-12-28 3:02 pm Purchase |
2020-12-22 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Pura Vida Investments, LLC | 31,667 8.880% |
31,667 (New Position) |
Filing History |
| 2020-12-23 4:42 pm Purchase |
2020-12-23 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Aspire Capital Fund LLC | 18,000 5.050% |
18,000 (New Position) |
Filing History |
| 2020-05-05 5:23 pm Purchase |
2020-04-24 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Eastern Capital LTD | 7,224 3.900% |
7,224 (New Position) |
Filing History |
| 2020-04-30 11:35 am Purchase |
2020-04-21 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
CVI Investments, Inc. | 18,646 9.900% |
18,646 (New Position) |
Filing History |